TCD follows a strategy of protecting its intellectual property for all of its products under development by patent filings in major markets worldwide. TCD's typical approach is to provide broad patent protection covering: the use of its major targets and additional targets as tumor markers; compound families; the use of its major targets and compounds in combination treatments; and methods for determining patient outcome and response to treatment.

All rights reserved. 2011 TCD Pharma                                         Legal Statement                                                          Designed by Freeman y la luz